NYSE$CYH

Community Health Systems Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Community Health Systems reported mixed results for Q1 2024, with revenue increasing slightly and a net loss, but adjusted EBITDA improved. The company focused on operational and strategic priorities.

Community Health Systems reported a slight increase in net operating revenues to $3.140 billion for Q1 2024, compared to $3.108 billion in the same period of 2023. The net loss attributable to stockholders was $(41) million, or $(0.32) per share, an improvement from $(51) million, or $(0.40) per share, in Q1 2023. Adjusted EBITDA increased to $378 million from $335 million year-over-year, and net cash provided by operating activities significantly increased to $96 million from $5 million.

  • Net operating revenues increased to $3.140 billion.
  • Net loss attributable to stockholders improved to $(41) million, or $(0.32) per share.
  • Adjusted EBITDA increased to $378 million.
  • Net cash provided by operating activities significantly increased to $96 million.

Headline financials

Total Revenue

$3.14B

Previous: $3.11B+1.0%
EPS

-$0.32

Previous: -$0.43+25.6%
Adjusted EBITDA

$378M

Previous: $335M+12.8%
Admissions

107.1K

Previous: 109.6K-2.3%
Adjusted admissions

236.1K

Previous: 245.9K-4.0%
Net cash from operating activities

$96M

No prior period
Licensed beds (at end of period)

11.9K

No prior period
Beds in service (at end of period)

10.1K

No prior period
Occupancy rate (average beds in service)

53.9%

Previous: 51.9%+3.9%
Number of hospitals (at end of period)

78

No prior period
Patient days

493.8K

No prior period
Average length of stay (days)

4.6

No prior period
Net inpatient revenues as % of net operating revenues

48.4%

Previous: 1463736000.0%-100.0%
Net outpatient revenues as % of net operating revenues

51.6%

Previous: 1644264000.0%-100.0%
Capital Expenditures

-$93M

Previous: -$122M+23.8%
Free Cash Flow

-$134M

Previous: -$173M+22.5%
Net Income

-$41M

Previous: -$51M+19.6%
Operating Income

$231M

Previous: $210M+10.0%
Gross Profit

$2.65B

Previous: $2.6B+2.0%
Cash & Equivalents

$48M

Previous: $144M-66.7%
Total Assets

$14.4B

Previous: $14.6B-1.4%
Stock-Based Comp

$6M

Previous: $6M+0.0%

Revenue & EPS history

CHS · Revenue · Quarterly

$3.14B

Q1 2024+1%vs Q1 2023
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Forward guidance

Community Health Systems reaffirmed its annual earnings guidance for 2024, which was originally provided on February 20, 2024. The guidance is based on historical operating performance, current trends, and other assumptions considered reasonable by the company.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+1.7%

Avg return

Earnings day

+3.6%

Avg return

5 days after

+2.4%

Avg return

30 days after

55%

38 / 69 earnings

Positive

+52.4%

Q4 2022

Best reaction

-41.0%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.3%+6.3%+3.0%
Q4 2025+5.7%+4.5%-13.5%
Q3 2025+25.8%+29.1%-4.3%
Q2 2025+0.0%-0.7%+7.7%
Q1 2025+18.5%+11.1%+51.0%
Q4 2024+7.8%+9.9%-22.4%
Q3 2024-22.6%-25.3%-33.5%
Q2 2024+17.5%+27.9%+24.9%
Q1 2024+9.8%+11.1%+20.9%
Q4 2023-28.4%-27.7%-11.6%
Q3 2023-7.0%-18.0%+12.1%
Q2 2023+11.8%-8.4%-18.9%
Q1 2023-39.9%-42.3%-48.4%
Q4 2022+52.4%+56.3%-0.6%
Q3 2022+36.8%+35.4%+68.9%
Q2 2022-41.0%-39.6%-38.6%
Q1 2022-4.2%-19.1%-40.1%
Q4 2021-10.1%-21.3%-15.1%
Q3 2021+19.1%+28.9%+28.4%
Q2 2021-6.4%-8.3%-13.1%
Q1 2021+0.3%+15.2%+37.9%
Q4 2020-7.6%-9.3%+28.3%
Q3 2020+19.2%+30.3%+78.3%
Q2 2020+14.2%+26.4%+37.8%
Q1 2020-7.4%-22.9%-11.8%
Q4 2019+42.7%+27.8%-44.2%
Q3 2019-17.0%-30.4%-32.6%
Q2 2019+12.9%+25.8%+39.7%
Q1 2019-1.7%-4.0%-19.9%
Q4 2018+12.8%+21.4%+8.5%
Q3 2018-6.3%+20.0%+33.3%
Q2 2018+2.3%+9.5%+16.7%
Q1 2018+34.7%+26.5%+8.2%
Q4 2017-11.6%-15.0%-31.6%
Q3 2017-23.1%-26.6%-26.3%
Q2 2017-7.8%-8.8%+6.9%
Q1 2017+19.9%+11.7%+2.8%
Q4 2016+33.8%+33.6%+21.7%
Q3 2016+0.8%+4.9%+3.0%
Q2 2016-1.5%-0.5%-19.3%
Q1 2016-22.1%
Q4 2015-22.1%
Q3 2015-2.4%
Q2 2015+1.2%
Q1 2015-7.6%
Q4 2014+1.2%
Q3 2014-5.0%
Q2 2014-4.9%
Q1 2014-7.2%
Q4 2013+0.3%
Q3 2013-0.3%
Q2 2013+2.2%
Q1 2013+4.7%
Q4 2012+1.4%
Q3 2012+2.4%
Q2 2012-4.3%
Q1 2012+5.2%
Q4 2011+5.3%
Q3 2011-2.7%
Q2 2011-6.4%
Q1 2010-3.5%
Q1 2011+0.1%
Q4 2008+8.0%
Q4 2010+8.0%
Q3 2009+2.0%
Q3 2010+2.0%
Q4 2009+4.3%
Q2 2009+4.3%
Q2 2010+4.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro